Submit your candidate for the Fierce 15

As we first noted yesterday, FierceBiotech will reveal the 2010 class of Fierce 15 companies later this month, and readers are being offered a chance to nominate a drug developer for this special report. So if you know of a biotech company with great science, a great staff and enormous potential, here's a chance to put them in the spotlight. Click the link to fill out the form. - John Carroll (twitter | email)

Suggested Articles

After seeing later stage trials come through in obesity, Novo Nordisk is canning two projects that were aiming to help reduce patients’ weight.

T-knife has raised €66 million ($78 million) to take four prospects from its TCR-T-cell platform into the clinic in solid tumor indications.

The NIH is starting with Eli Lilly and AbCellera's COVID-19 antibody but could add more prospects as the trial goes on.